Injection
Tirzepatide + B12
A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with vitamin B12 for energy.
Starting at $198/mo
Weight lossAnticonvulsantOral
RxPrescription onlyTaken by mouth · Once a day · 25–50 mg · Weight loss · Anticonvulsant · Oral
Starting at $79/mo
Oral topiramate, an anticonvulsant used off-label for weight loss. Topiramate may reduce appetite and increase satiety, supporting gradual, steady weight loss.
How many tablets per month?
You'll receive 30 tablets per month. $99 billed monthly. Cancel anytime.
Real prices from our pharmacy. Longer plans cost less per month and are billed up front. Pause or cancel anytime.
Every plan includes
(anticonvulsant, carbonic anhydrase inhibitor)
Topiramate is approved for seizures and migraines. Off-label use for weight loss is based on its appetite-suppressing effects. Mechanism likely involves carbonic anhydrase inhibition and effects on GABA signaling, which may reduce hunger and increase fullness.
Modest to moderate
average 5–9% weight loss with topiramate plus lifestyle
Topiramate produces modest to moderate weight loss, generally less than GLP-1 medications but more than metformin alone. Results depend heavily on diet and activity. Cognitive side effects (difficulty concentrating, word-finding) occur in some users.

Day 1
A US-licensed physician reviews your health, metabolism, and why an oral medication may help you. Explains the medication's mechanism and what to expect.
Week 1–2
Start your dose. You may feel appetite changes within days, or changes may take weeks. GI effects (metformin) or mood changes (naltrexone) are possible early on.

Weeks 3–6
Your appetite and eating patterns shift. Fullness comes sooner. Your physician checks in and may adjust your dose based on response and tolerability.

Months 2–3
Steady, gradual weight loss. Metabolism and appetite remain improved. Your physician monitors for any side effects and adjusts dosing.

Beyond
Maintenance: your physician works with you to hold results or adjust as your body changes. Long-term monitoring ensures ongoing safety.
Weight loss
steady but modest; depends on diet and activity
Appetite change
reduced hunger or improved fullness is common
Energy and metabolism
gradual improvement with weight loss and diet
Medical oversight
your physician monitors for side effects and efficacy
Individual results vary. Benefits reflect what Zepym Health members commonly report to their physician at check-ins; they are not the results of a clinical trial.
Important safety information and common side effects
Oral weight-loss medications (metformin, naltrexone, topiramate) have different safety profiles. Metformin: GI side effects (nausea, diarrhea) common, especially initially; not for severe kidney disease. Naltrexone: generally well-tolerated; headache or dizziness possible. Topiramate: cognitive effects ('topiramate fog', difficulty concentrating, word-finding) in 10–15%; kidney stones possible. All are off-label for weight loss; efficacy and safety are not FDA-approved for this use. Tell your physician about all medications, kidney disease, and any history of kidney stones (topiramate). Stop and seek care for severe GI pain (metformin), severe headache, allergic reactions, or eye pain (topiramate).
Topiramate is an anti-seizure drug used off label for weight. The evidence is a pooled set of trials in overweight and obese adults, many with other conditions.
Ten randomized trials with 3,320 participants: topiramate gave 5.34 kg more weight loss than placebo (meta-analysis, 2011).
Kramer et al., Obesity Reviews 2011 (PubMed 21438989)In trials giving 96 to 200 mg a day, loss was 6.58 kg in trials longer than 28 weeks and 4.11 kg in shorter trials.
Kramer et al., Obesity Reviews 2011 (PubMed 21438989)People on topiramate were about twice as likely to stop for adverse events as those on placebo. The common effects were paresthesia (tingling), taste impairment and psychomotor disturbances.
Kramer et al., Obesity Reviews 2011 (PubMed 21438989)What the studies found
Trial results are for the prescription tablet at the doses studied, as averages. The trials mixed people with and without diabetes, and these sources contain no separate analysis for people without diabetes. Compounded forms were not studied.
What this does not say
Topiramate in randomized trials produces average 5–9% weight loss, often combined with phentermine for larger effect. Off-label use for weight loss alone is supported by mechanism and clinical experience.
Weight loss is gradual (weeks to months). Some users experience cognitive effects ('topiramate fog'); these often improve with dose adjustment.
Connect with a physician
Answer a few questions online and a US-licensed physician reviews your health, history and goals to make sure treatment is right for you. 100% online. No in-person visit required.
Get your discreet shipment
If approved, your treatment is compounded by a US-licensed, LegitScript-certified pharmacy, inspected for quality, and shipped discreetly to your door.
Receive continuous support
Start with one goal, then keep building over time. Unlimited physician messaging, easy refills and dose adjustments, all from the Zepym Health app.
Taken by mouth, once a day, at bedtime. The starting prescription is 1 tablet (25 mg) each time. Your physician sets your own dose and it is printed on your label.
The pharmacy carries 2: 25 mg, 50 mg. Your physician chooses which one you get.
30 tablets at the starting strength, shipped to your door from a licensed US pharmacy.
Yes, moderately. Topiramate reduces appetite and increases fullness in many users. Results are smaller and slower than GLP-1 drugs but real, especially with diet and exercise. Your physician monitors for cognitive side effects and adjusts doses if needed.
These medications are FDA-approved for other conditions (diabetes, seizures, addiction) but not specifically for weight loss. Off-label use is legal and common; your physician prescribes based on research and experience.
That depends on your health profile, goals, and what side effects you can tolerate. Metformin is gentlest but least effective. Naltrexone is experimental. Topiramate is moderate. Your physician will recommend based on your individual needs.
Yes, some combinations are used; for example, topiramate plus phentermine. However, combining multiple weight-loss medications requires careful physician oversight.
If you see minimal effect after 8–12 weeks, your physician may increase the dose, switch medications, or recommend GLP-1 drugs like semaglutide or tirzepatide for stronger effect.

Topiramate educational content reviewed by our physician
Scott Nass, MD Doctor of Medicine, board-certified in Family Medicine
Charles R. Drew University and David Geffen School of Medicine at UCLA. Family Medicine residency at Ventura County Medical Center.
Injection
A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with vitamin B12 for energy.
Starting at $198/mo
Injection
A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with vitamin B12 for energy.
Starting at $99/mo
Injection
A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with glycine for better tolerance.
Starting at $198/mo
Injection
A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with glycine for better tolerance.
Starting at $99/mo
Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Compounded medications are not FDA-approved brand-name products.